Xu T, Zhang W-G, Sun J, Zhang Y, Lu J-F, Han H-B, Zhou C-M, Yan J-H
Department of Anatomy and Histology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Department of Radiology, Peking University Third Hospital, Beijing 100191, China; Beijing Key Lab of Magnetic Resonance Imaging Technology, Beijing 100191, China.
Neuroscience. 2015 Jul 23;299:18-27. doi: 10.1016/j.neuroscience.2015.04.058. Epub 2015 Apr 30.
The enhanced vascular permeability is a major early brain injury following subarachnoid hemorrhage (SAH). However, its mechanism is not clear yet. In this work, we explored its potential mechanism and investigated the roles of thrombomodulin (TM) in maintaining microvascular integrity after SAH. SAH models were established in adult male ICR mice (28-32 g) by endovascular perforation. TM was immediately administered by femoral vein injection following SAH. The brain water content, Evans Blue content and neurological functions were evaluated. Brain edema was also detected by magnetic resonance imaging (MRI) (T2 map). The siRNA technique, enzyme-linked immunosorbent assay (ELISA), immunofluorescence staining and western blotting were performed to explore the potential mechanism of TM treatment. The number of microthrombi in the hippocampus microvessels was also recorded. TM significantly decreased brain water content and Evans Blue content, alleviated brain edema and neurological deficits after SAH. The plasma concentration of activated protein C was increased after TM treatment. In addition, the levels of phospho-p38MAPK, phospho-p53, cleaved caspase-3, phospho-NF-κB (p65) were markedly decreased. Additionally, the loss of VE-cadherin and Occludin (markers of vascular integrity) and the number of microthrombi in the hippocampus were also reduced. Our results indicated that TM has protective effects on preserving microvascular integrity following SAH partly through preserving endothelial junction proteins and quenching apoptosis/inflammation in endothelial cells via blocking p38MAPK-p53/NF-κB (p65) pathway.
血管通透性增强是蛛网膜下腔出血(SAH)后主要的早期脑损伤。然而,其机制尚不清楚。在本研究中,我们探讨了其潜在机制,并研究了血栓调节蛋白(TM)在SAH后维持微血管完整性中的作用。通过血管内穿刺在成年雄性ICR小鼠(28 - 32 g)中建立SAH模型。SAH后立即通过股静脉注射给予TM。评估脑含水量、伊文思蓝含量和神经功能。还通过磁共振成像(MRI)(T2图)检测脑水肿。采用小干扰RNA技术、酶联免疫吸附测定(ELISA)、免疫荧光染色和蛋白质印迹法来探讨TM治疗的潜在机制。同时记录海马微血管中微血栓的数量。TM显著降低了SAH后脑含水量和伊文思蓝含量,减轻了脑水肿和神经功能缺损。TM治疗后活化蛋白C的血浆浓度升高。此外,磷酸化p38丝裂原活化蛋白激酶、磷酸化p53、裂解的半胱天冬酶 - 3、磷酸化核因子κB(p65)的水平明显降低。另外,血管内皮钙黏蛋白和闭合蛋白(血管完整性标志物)的丢失以及海马中微血栓的数量也减少。我们的结果表明,TM对SAH后微血管完整性的保护作用部分是通过保护内皮连接蛋白以及通过阻断p38丝裂原活化蛋白激酶 - p53/核因子κB(p65)途径抑制内皮细胞凋亡/炎症来实现的。